Xora Innovation logo

Xora Innovation

Crunchbase
Pitchbook
Crunchbase

Deals on record

6

Common Fundraising Type

Series A

Vsim logo
Vsim

Physics simulation

Xora logo
Tru Arrow logo
Samsung Next logo
Koro Capital logo
IQ Capital logo
Lakestar logo
Factorial Fund logo
EQT Ventures logo

Vsim is developing a high-performance physics simulation framework for robotics training and other applications, leveraging advanced algorithms and multi-core hardware for significant performance improvements.

Seed
$21.5M
09/25/2024
Article
HyperLight logo
HyperLight

Thin film lithium niobate

Summit Partners logo
Xora Innovation logo
Foothill Ventures logo

HyperLight Corporation develops high-speed, energy-efficient thin film lithium niobate photonic integrated circuits for AI/data center infrastructure, telecommunications optical networks, and high-performance computing.

Series B
$37M
09/23/2024
Article
Aether Fuels logo
Aether Fuels

Climate Technology

Xora Innovation logo
TechEnergy Ventures logo
JetBlue Ventures logo
Foothill Ventures logo
Doral Energy Tech Ventures logo

Aether Fuels is a climate tech company that produces sustainable liquid fuels from waste carbon streams for the aviation and ocean shipping industries.

Series A
$8.5M
12/18/2023
Article
Talus Renewables logo
Talus Renewables

Renewable Energy

Xora Innovation logo
Rice Investment Group logo
Material Impact logo
Cavallo Ventures logo

Talus Renewables is a renewable energy infrastructure company that has raised $22 million in a Series A financing round to develop the first commercial, modular, zero-carbon green ammonia system.

Series A
$22M
11/06/2023
Article

Cosmos Innovation is an AI-first company focused on developing perovskite silicon tandem (PST) solar cell technology, with plans to build the world's first self-learning fab in the solar and semiconductor space.

Series A
$19.7M
10/20/2023
Article
Automera logo
Automera

Biotechnology

ClavystBio logo
Accelerator Life Science Partners logo
Xora Innovation logo
EDBI logo

Automera is a biotechnology company that develops autophagy-targeting chimera small molecules (AUTACs) for the treatment of cancer and other diseases, using quantum chemistry and AI-enabled drug discovery tools to generate novel therapeutic leads.

Series A
$16M
09/27/2023
Article